NATCO PHARMA LTD.

NSE : NATCOPHARMBSE : 524816ISIN CODE : INE987B01026Industry : Pharmaceuticals & DrugsHouse : Natco
BSE1022.0516.05 (+1.6 %)
PREV CLOSE ( ) 1006.00
OPEN PRICE ( ) 1011.05
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 1022.05 (260)
VOLUME 62636
TODAY'S LOW / HIGH ( )1007.10 1034.95
52 WK LOW / HIGH ( )560.15 1107.85
NSE1022.8017.1 (+1.7 %)
PREV CLOSE( ) 1005.70
OPEN PRICE ( ) 1013.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 1022.80 (6369)
VOLUME 639513
TODAY'S LOW / HIGH( ) 1005.00 1034.70
52 WK LOW / HIGH ( )563 1108.35

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.